SCHEDULE 13G/A 0001178913-25-002315 0001679543 XXXXXXXX LIVE 1 Ordinary Shares, NIS 0.90 par value 09/30/2025 0000808439 TAT Technologies Ltd M8740S227 5 Hamelacha Street Netanya L3 4250540 Rule 13d-1(c) Phoenix Financial Ltd. b L3 0 1219933.67 0 1219933.67 1219933.67 N 9.53 CO With regard to rows (6), (8), (9) and (11), the beneficial ownership of the securities reported herein is described in Item 4(a). Row (11) is Based on 12,807,656 Ordinary Shares outstanding as of October 26, 2025 (as reported on Bloomberg LP). TAT Technologies Ltd 5 Hamelacha Street, Netanya, Israel, 4250540 Phoenix Financial Ltd. The securities reported herein are beneficially owned by various direct or indirect, majority or wholly-owned subsidiaries of Phoenix Financial Ltd. (the "Subsidiaries"). The Subsidiaries manage their own funds and/or the funds of others, including for holders of exchange-traded notes or various insurance policies, members of pension or provident funds, unit holders of mutual funds, and portfolio management clients. Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions. The address of the Phoenix Financial Ltd. is Derech Hashalom 53, Givataim, 53454, Israel. Phoenix Financial Ltd. - Israel Y See row 9 of cover page of each reporting person. Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission by either the Filing Persons or Subsidiaries that a group exists for purposes of Section 13(d) of the Securities Exchange Act of 1934 or for any other purpose, and each reporting person disclaims the existence of any such group. In addition, each of the Filing Persons and Subsidiaries disclaims any beneficial ownership of the securities covered by this report in excess of their actual pecuniary interest therein. This Statement shall not be construed as an admission by the Filing Persons or Subsidiaries that they are the beneficial owners of any of the Ordinary Shares covered by this Statement. As of September 30, 2025, the securities reported herein were held as follows: 459,821.67 ordinary shares (representing 3.59% of the total ordinary shares outstanding) beneficially owned by The Phoenix Investments House - trust funds. 709,994 ordinary shares (representing 5.54% of the total ordinary shares outstanding) beneficially owned by Partnership for Israeli shares (1). 50,118 ordinary shares (representing 0.39% of the total ordinary shares outstanding) beneficially owned by Partnership for investing in shares indexes (1). (1) All ownership rights in this partnership belong to companies that are part of Phoenix Group. The amount of ownership rights held by such companies in the partnership changes frequently according to a mechanism provided in the partnership agreement. See row 11 of cover page of each reporting person See row 5 of cover page of each reporting person See row 6 of cover page of each reporting person and note in Item 4(a) above See row 7 of cover page of each reporting person See row 8 of cover page of each reporting person and note in Item 4(a) above Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 1 - Notice of resolution of the Board of Directors of Phoenix Financial Ltd., dated as of December 12, 2019 (incorporated herein by reference to Exhibit 1 to the Schedule 13G filed on October 6, 2020). Phoenix Financial Ltd. /s/ Eli Schwartz 11/05/2025 /s/ Haggai Schreiber 11/05/2025 Signature duly authorized by resolution of the Board of Directors, notice of which is attached as Exhibit 1 to this Schedule 13G.